Wakuma Wakene Jifar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wakuma Wakene Jifar has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Ahmed Salem BaHammam
King Saud University
4 shared publications - Dilshad Manzar
Department of Nursing, College of Applied Medical Sciences, Majmaah University, Majmaah, Saudi Arabia
3 shared publications - Abdulrhman Albougami
Department of Nursing, College of Applied Medical Sciences, Majmaah University, Majmaah, Saudi Arabia
2 shared publications - Dejen Nureye
Department of Pharmacy
2 shared publications Gebiso Roba Debele
Mattu University
2 shared publications- Gebiso Roba Debele
Department of Public Health, College of Health Sciences, Mattu University, Mattu, Ethiopia
2 shared publications
Latest Publications
- Open Access
- 2 December 2025
- Published by Cambridge University Press (CUP) in Primary Health Care Research & Development
- Vol. 26, e99
Severity of migraine-like symptoms and its impact on executive functions in university students: a mediation model analysis
Background: The influence of severity of migraine-like symptoms on different levels of executive functions is not well established. In this study, we investigate the impact of severity of migraine-like symptoms on the relationship between core-level executive functions (attention and memory) and fluid intelligence. Methods: A cross-sectional study was conducted on university students (n = 427, age = 20.7 + 1.8 years). Participants completed self-report measures of Migraine Screen Questionnaire (MS-Q), single-item visual analogue scales (VASs) each for the subjective accounts of problems in core-level executive functions (attention and memory), and a single-item VAS for problems in fluid intelligence (PFI), and sociodemographics tool. The mediation effect model was used to determine the relationship. Results: The study found a correlation between i) attention problems and severity of migraine-like symptoms (b = 0.109, standard error (SE) = 0.026, p < 0.001), ii) severity of migraine-like symptoms and memory problems (b = 0.318, SE = 0.076, p < 0.001), and iii) severity of migraine-like symptoms – PFI (b = 0.243, SE = 0.083, p < 0.003), with an indirect effect of attention problems on memory problems and PFI and no correlation between severity of migraine-like symptoms and PFI. Conclusions: Self-reported accounts of problems in core-level executive functions and fluid intelligence are correlated. Severity of migraine-like symptoms may mediate the inter-relationship between some core-level and higher-level executive functions.
- 2 December 2025
- Published by Cambridge University Press (CUP) in Primary Health Care Research & Development
- Vol. 26, e99
Open AccessSeverity of migraine-like symptoms and its impact on executive functions in university students: a mediation model analysis
Background: The influence of severity of migraine-like symptoms on different levels of executive functions is not well established. In this study, we investigate the impact of severity of migraine-like symptoms on the relationship between core-level executive functions (attention and memory) and fluid intelligence. Methods: A cross-sectional study was conducted on university students (n = 427, age = 20.7 + 1.8 years). Participants completed self-report measures of Migraine Screen Questionnaire (MS-Q), single-item visual analogue scales (VASs) each for the subjective accounts of problems in core-level executive functions (attention and memory), and a single-item VAS for problems in fluid intelligence (PFI), and sociodemographics tool. The mediation effect model was used to determine the relationship. Results: The study found a correlation between i) attention problems and severity of migraine-like symptoms (b = 0.109, standard error (SE) = 0.026, p < 0.001), ii) severity of migraine-like symptoms and memory problems (b = 0.318, SE = 0.076, p < 0.001), and iii) severity of migraine-like symptoms – PFI (b = 0.243, SE = 0.083, p < 0.003), with an indirect effect of attention problems on memory problems and PFI and no correlation between severity of migraine-like symptoms and PFI. Conclusions: Self-reported accounts of problems in core-level executive functions and fluid intelligence are correlated. Severity of migraine-like symptoms may mediate the inter-relationship between some core-level and higher-level executive functions.
- Open Access
- 20 May 2025
- Published by Sechenov University in The BRICS Health Journal
- Vol. 2 (1) , 53-68
Multi-targeted molecular docking, pharmacokinetic analysis, and drug-likeness evaluation of alkaloids for anti-diabetic drug development
Diabetes mellitus is a global health challenge, particularly in low-income regions, leading to severe complications. Plant-derived alkaloids offer potential as alternatives to conventional therapies. This study evaluated 31 alkaloids for antidiabetic drug development through molecular docking, pharmacokinetics, and drug-likeness analyses. Four standard drugs (epalrestat, metformin, acarbose, glibenclamide) and four targets (aldose reductase, adenosine monophosphate-activated protein kinase, a-glucosidase, protein tyrosine phosphatase 1B) were used for computational simulations.Molecular docking revealed that alkaloids mahanimbine (-11.5 kcal/mol), echinulin (11.3 kcal/mol), coptisine (-10.9 kcal/mol), and groenlandicine (-9.7 kcal/mol) have substantial binding affinities against aldose reductase compared to epalrestat (-9.3 Kcal/mol). In contrast to metformin (-4.8 kcal/mol), coptisine, echinulin, sanguinarine, and groelandicine showed superior binding affinities against adenosine monophosphateactivated protein kinase. In comparison to acarbose (-8.4 Kcal/mol), coptisine (-9.7 Kcal/mol), sanguinarine (-9.3 Kcal/mol), mahanimbine (-8.9 Kcal/mol), and echinulin (-8.9 Kcal/mol) demonstrated better docking scores against a-glucosidase. Jatrorrhizine, coptisine, sanguinarine, mahanimbine and echinuline respectively demonstrated higher binding scores of 8.8, -7.5, -7.5 and -7.2 Kcal/mol against protein tyrosine phosphatase 1B than glibenclamide (-7.0 Kcal/mol). Most alkaloids adhered to Lipinski’s rule, except casuarine 6-O-a-glucoside and conophylline. Pharmacokinetics identified pinoline as highly bioavailable and central nervous system penetrant, while conophylline had poor bioavailability.The study concluded that alkaloids including mahanimbine, echinulin, coptisine, groenlandicine, sanguinarine, and jatrorrhizine show strong binding affinities and favorable pharmacokinetic properties, requiring further in vitro and in vivo studies for therapeutic validation
- 20 May 2025
- Published by Sechenov University in The BRICS Health Journal
- Vol. 2 (1) , 53-68
Open AccessMulti-targeted molecular docking, pharmacokinetic analysis, and drug-likeness evaluation of alkaloids for anti-diabetic drug development
Diabetes mellitus is a global health challenge, particularly in low-income regions, leading to severe complications. Plant-derived alkaloids offer potential as alternatives to conventional therapies. This study evaluated 31 alkaloids for antidiabetic drug development through molecular docking, pharmacokinetics, and drug-likeness analyses. Four standard drugs (epalrestat, metformin, acarbose, glibenclamide) and four targets (aldose reductase, adenosine monophosphate-activated protein kinase, a-glucosidase, protein tyrosine phosphatase 1B) were used for computational simulations.Molecular docking revealed that alkaloids mahanimbine (-11.5 kcal/mol), echinulin (11.3 kcal/mol), coptisine (-10.9 kcal/mol), and groenlandicine (-9.7 kcal/mol) have substantial binding affinities against aldose reductase compared to epalrestat (-9.3 Kcal/mol). In contrast to metformin (-4.8 kcal/mol), coptisine, echinulin, sanguinarine, and groelandicine showed superior binding affinities against adenosine monophosphateactivated protein kinase. In comparison to acarbose (-8.4 Kcal/mol), coptisine (-9.7 Kcal/mol), sanguinarine (-9.3 Kcal/mol), mahanimbine (-8.9 Kcal/mol), and echinulin (-8.9 Kcal/mol) demonstrated better docking scores against a-glucosidase. Jatrorrhizine, coptisine, sanguinarine, mahanimbine and echinuline respectively demonstrated higher binding scores of 8.8, -7.5, -7.5 and -7.2 Kcal/mol against protein tyrosine phosphatase 1B than glibenclamide (-7.0 Kcal/mol). Most alkaloids adhered to Lipinski’s rule, except casuarine 6-O-a-glucoside and conophylline. Pharmacokinetics identified pinoline as highly bioavailable and central nervous system penetrant, while conophylline had poor bioavailability.The study concluded that alkaloids including mahanimbine, echinulin, coptisine, groenlandicine, sanguinarine, and jatrorrhizine show strong binding affinities and favorable pharmacokinetic properties, requiring further in vitro and in vivo studies for therapeutic validation
- Open Access
- 6 September 2024
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 24 (1) , 1-14
Assessment of factors associated with self-medication practices during the COVID-19 pandemic in southwestern Ethiopia: a community-based cross-sectional survey
Self-medication practices involve the use of medications without healthcare professional requests. The threat of coronavirus disease 2019 (COVID-19) caused the practice of a fittest to survive action, with the assumption that something is better than nothing. Moreover, owing to the lack of effective treatment for COVID-19, the general public has shifted toward self-medication and symptomatic treatment, with approximately 80% of people stockpiling medication for use during the pandemic. Thus, this study aimed to assess the factors associated with self-medication practices during the COVID-19 pandemic crisis in southwestern Ethiopia. A community-based cross-sectional study design was employed at selected drug retail outlets in southwestern Ethiopia for 415 community pharmacy clients from July 1, 2021, to September 1, 2021. Purposive sampling techniques were employed to select five drug retail outlets on the basis of high patient flows, and we took the study participants until the required quota allotted to each selected drug retail outlet had been filled. Bivariable and multivariable logistic regression analyses were employed to identify factors associated with self-medication. AORs with 95% CIs were used to report associations, and the level of significance was set at P < 0.05. Results: Self-medication was significantly associated with being female (AOR 3.51, 95% CI 1.04–12.41), having a college education or above (AOR 47, 95% CI 4.32–55.21), time wastage at public health facilities (AOR 2.71, 95% CI 3.47–5.21), being afraid of contracting COVID-19 (AOR 0.006, 95% CI 0.004–0.185), and having high fees at public health facility (AOR 0.006, 95% CI 0.004–0.185). The most frequently used medications to treat or prevent the COVID-19 pandemic were analgesics (42.4%) and cold medicines (29.5%). Headache (22.2%), fever (13.2%), respiratory infection (14.3%), and cold (21.4%) were the most frequently reported symptoms of the COVID-19 pandemic. This study revealed high self-medication practices among study area residents during the COVID-19 pandemic. The primary reasons for self-medication in the context of COVID-19 are fear of the pandemic and time wastage at public health facilities. Therefore, special attention should be given to educating public and health care providers on the types of illnesses that can be self-diagnosed and self-treated and the types of drugs to be used for self-medication.
- 6 September 2024
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 24 (1) , 1-14
Open AccessAssessment of factors associated with self-medication practices during the COVID-19 pandemic in southwestern Ethiopia: a community-based cross-sectional survey
Self-medication practices involve the use of medications without healthcare professional requests. The threat of coronavirus disease 2019 (COVID-19) caused the practice of a fittest to survive action, with the assumption that something is better than nothing. Moreover, owing to the lack of effective treatment for COVID-19, the general public has shifted toward self-medication and symptomatic treatment, with approximately 80% of people stockpiling medication for use during the pandemic. Thus, this study aimed to assess the factors associated with self-medication practices during the COVID-19 pandemic crisis in southwestern Ethiopia. A community-based cross-sectional study design was employed at selected drug retail outlets in southwestern Ethiopia for 415 community pharmacy clients from July 1, 2021, to September 1, 2021. Purposive sampling techniques were employed to select five drug retail outlets on the basis of high patient flows, and we took the study participants until the required quota allotted to each selected drug retail outlet had been filled. Bivariable and multivariable logistic regression analyses were employed to identify factors associated with self-medication. AORs with 95% CIs were used to report associations, and the level of significance was set at P < 0.05. Results: Self-medication was significantly associated with being female (AOR 3.51, 95% CI 1.04–12.41), having a college education or above (AOR 47, 95% CI 4.32–55.21), time wastage at public health facilities (AOR 2.71, 95% CI 3.47–5.21), being afraid of contracting COVID-19 (AOR 0.006, 95% CI 0.004–0.185), and having high fees at public health facility (AOR 0.006, 95% CI 0.004–0.185). The most frequently used medications to treat or prevent the COVID-19 pandemic were analgesics (42.4%) and cold medicines (29.5%). Headache (22.2%), fever (13.2%), respiratory infection (14.3%), and cold (21.4%) were the most frequently reported symptoms of the COVID-19 pandemic. This study revealed high self-medication practices among study area residents during the COVID-19 pandemic. The primary reasons for self-medication in the context of COVID-19 are fear of the pandemic and time wastage at public health facilities. Therefore, special attention should be given to educating public and health care providers on the types of illnesses that can be self-diagnosed and self-treated and the types of drugs to be used for self-medication.
- Open Access
- 21 October 2023
- Published by Springer Nature in Archives of Public Health
- Vol. 81 (1) , 1-11
Why too soon? Predictors of time to diabetic peripheral neuropathy among newly diagnosed diabetes mellitus patients: a multicenter follow-up study at health-care setting of Ethiopia
Due to the rising number of diabetic patients, the burden of diabetic peripheral neuropathy (DPN) is clearly posing a major challenge to the long-term viability of the health-care system. Despite this, most DPN epidemiological research in eastern Africa, including Ethiopia, has so far been limited to survey studies. Thus, we determined the incidence of DPN and its predictors among diabetic patients in tertiary health-care setting of southwest Ethiopia. A multicenter retrospective follow-up study was carried out on 567 randomly selected diabetic patients. Data were entered using Epi-Data v4.6 and analyzed using R v4.0.4. The survival curves were estimated using the Kaplan-Meier, and compared using Log-rank test between groups of categorical variables. The PHA were evaluated using the Schoenfeld residuals test. Multivariable Gompertz proportional hazard model was used to examine the predictors of DPN at 5% level of significance. Overall, of 567 DM patients 119 developed DPN with an incidence rate of 3.75, 95%CI [3.13, 4.49] per 100 PY. About 15.13% and 69% of DPN cases occurred within 2 and 5 years of DM diagnosis, respectively. In the multivariable Gompertz PH model, being female [AHR = 1.47; 95% CI (1.01, 2.15)], T2DM [AHR = 3.49 95% CI (1.82, 6.71)], having diabetic retinopathy [AHR = 1.9 95% CI (1.25, 2.91)], positive proteinuria [AHR = 2.22 95% CI (1.35, 3.65)], being obese [AHR = 3.94 95% CI (1.2, 12.89)] and overweight [AHR = 3.34 95% CI (1.09, 10.25)] significantly predicts the future risk of DPN. Nearly, 7 in 10 of DPN cases occurred within short period of time (5 year) of DM diagnosis. Being female, T2DM, DR, positive proteinuria, obese and overweight significantly predicts the risk of DPN. Therefore, we recommend screening and early diagnosis of diabetes with its complication. While doing so, attention should be given for DM patients with DR and positive proteinuria at baseline.
- 21 October 2023
- Published by Springer Nature in Archives of Public Health
- Vol. 81 (1) , 1-11
Open AccessWhy too soon? Predictors of time to diabetic peripheral neuropathy among newly diagnosed diabetes mellitus patients: a multicenter follow-up study at health-care setting of Ethiopia
Due to the rising number of diabetic patients, the burden of diabetic peripheral neuropathy (DPN) is clearly posing a major challenge to the long-term viability of the health-care system. Despite this, most DPN epidemiological research in eastern Africa, including Ethiopia, has so far been limited to survey studies. Thus, we determined the incidence of DPN and its predictors among diabetic patients in tertiary health-care setting of southwest Ethiopia. A multicenter retrospective follow-up study was carried out on 567 randomly selected diabetic patients. Data were entered using Epi-Data v4.6 and analyzed using R v4.0.4. The survival curves were estimated using the Kaplan-Meier, and compared using Log-rank test between groups of categorical variables. The PHA were evaluated using the Schoenfeld residuals test. Multivariable Gompertz proportional hazard model was used to examine the predictors of DPN at 5% level of significance. Overall, of 567 DM patients 119 developed DPN with an incidence rate of 3.75, 95%CI [3.13, 4.49] per 100 PY. About 15.13% and 69% of DPN cases occurred within 2 and 5 years of DM diagnosis, respectively. In the multivariable Gompertz PH model, being female [AHR = 1.47; 95% CI (1.01, 2.15)], T2DM [AHR = 3.49 95% CI (1.82, 6.71)], having diabetic retinopathy [AHR = 1.9 95% CI (1.25, 2.91)], positive proteinuria [AHR = 2.22 95% CI (1.35, 3.65)], being obese [AHR = 3.94 95% CI (1.2, 12.89)] and overweight [AHR = 3.34 95% CI (1.09, 10.25)] significantly predicts the future risk of DPN. Nearly, 7 in 10 of DPN cases occurred within short period of time (5 year) of DM diagnosis. Being female, T2DM, DR, positive proteinuria, obese and overweight significantly predicts the risk of DPN. Therefore, we recommend screening and early diagnosis of diabetes with its complication. While doing so, attention should be given for DM patients with DR and positive proteinuria at baseline.
- Open Access
- 1 March 2023
- Published by Taylor & Francis in Journal of Experimental Pharmacology
- Vol. ume 15, 139-147
In vitro Evaluation of Antibacterial Activity of Synthetic Zeolite Supported AgZno Nanoparticle Against a Selected Group of Bacteria
Background: The development of novel and intriguing nanoparticle (NP)-based materials with antibacterial activity has recently received attention due to the problem of bacterial resistance to conventional antibiotics becoming more and more frequent. Thus, this study aimed to investigate the antibacterial effectiveness of a synthetic zeolite-supported AgZnO nanoparticle against selected bacteria in vitro. Methods: Using the disc diffusion method, the antibacterial activity of synthetic zeolite-supported AgZnO nanoparticles was assessed against Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli). Zinc oxide (ZnO) and Ag/ZnO nanoparticles were used to create the zeolite-supported Ag/ZnO composite. Chloramphenicol was used as a standard drug. The nanoparticles and composites were characterized using powder X-ray diffraction (XRD), Fourier transform infrared (FTIR), and atomic absorption spectroscopy (AAS). Results: Synthetic zeolite-supported AgZnO nanoparticles showed promising antibacterial properties with the largest zone of inhibition against S. aureus bacteria in comparison to E. coli. The synthetic zeolite-supported AgZnO nanoparticle displayed a zone of inhibition against S. aureus and E. coli without a remarkable difference compared to the respective standard drug (Chloramphenicol). Zinc peaks were visible in the X-ray diffractograms, which supported the theory that the characteristic hexagonal wurtzite structure of zinc oxide was present. Conclusion: All types of ZnO, AgZnO, and AgZnO-Zeolite showed wide-spectrum activity with better effect against gram-positive bacteria, while the Zeolite-Ag/ZnO composite showed even better antibacterial activity. The findings suggest a potential bactericide that needs further evaluation in future studies was observed in synthetic zeolite-supported Ag/ZnO nanoparticles.
- 1 March 2023
- Published by Taylor & Francis in Journal of Experimental Pharmacology
- Vol. ume 15, 139-147
Open AccessIn vitro Evaluation of Antibacterial Activity of Synthetic Zeolite Supported AgZno Nanoparticle Against a Selected Group of Bacteria
Background: The development of novel and intriguing nanoparticle (NP)-based materials with antibacterial activity has recently received attention due to the problem of bacterial resistance to conventional antibiotics becoming more and more frequent. Thus, this study aimed to investigate the antibacterial effectiveness of a synthetic zeolite-supported AgZnO nanoparticle against selected bacteria in vitro. Methods: Using the disc diffusion method, the antibacterial activity of synthetic zeolite-supported AgZnO nanoparticles was assessed against Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli). Zinc oxide (ZnO) and Ag/ZnO nanoparticles were used to create the zeolite-supported Ag/ZnO composite. Chloramphenicol was used as a standard drug. The nanoparticles and composites were characterized using powder X-ray diffraction (XRD), Fourier transform infrared (FTIR), and atomic absorption spectroscopy (AAS). Results: Synthetic zeolite-supported AgZnO nanoparticles showed promising antibacterial properties with the largest zone of inhibition against S. aureus bacteria in comparison to E. coli. The synthetic zeolite-supported AgZnO nanoparticle displayed a zone of inhibition against S. aureus and E. coli without a remarkable difference compared to the respective standard drug (Chloramphenicol). Zinc peaks were visible in the X-ray diffractograms, which supported the theory that the characteristic hexagonal wurtzite structure of zinc oxide was present. Conclusion: All types of ZnO, AgZnO, and AgZnO-Zeolite showed wide-spectrum activity with better effect against gram-positive bacteria, while the Zeolite-Ag/ZnO composite showed even better antibacterial activity. The findings suggest a potential bactericide that needs further evaluation in future studies was observed in synthetic zeolite-supported Ag/ZnO nanoparticles.
- Open Access
- 1 January 2023
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2023 (1) , 9187837
In VivoHypolipidemic, Hypoglycemic, Antihyperglycemic, andIn VitroAntioxidant Effects ofPodocarpus gracilisLeaf Extract and Fractions in Diabetic Mice
Background.Podocarpus gracilisis an evergreen, dioecious tree found in Ethiopia and other African nations. It can reach a height of 60 meters. Without any scientific validation, ethnobotanical studies conducted in Ethiopia revealed that thePodocarpus gracilisplant’s leaf is consumed orally to treat diabetes mellitus. Hence, this study aims to evaluate thein vivoblood glucose level lowering, lipid‐lowering, andin vitro‐free radical scavenging responses ofPodocarpus gracilis leaf extract and fractions on experimental mice induced with diabetes.Methods. Thein vitroantioxidant activity of PGC (Podocarpus gracilis) leaf extract was assessed by using a diphenyl‐2‐picrylhydrazyl (DPPH) assay. The oral glucose‐loaded, normoglycemic, and streptozotocin‐ (STZ‐) induced diabetic mouse models were employed. In the STZ‐induced mice model, the leaf extract and solvent fractions activity on serum lipid and weight were also measured. The extract and fractions were tested at 100, 200, and 400 mg/kg dosages. One‐way ANOVA was used to determine the statistical significance of BGL (blood glucose level) changes within and between groups, and Tukey’s post hoc multiple comparisons were then performed.Results. In the acute toxicity study ofPodocarpus gracilisleaf extract and fractions, there was no evidence of animal mortality at the maximum dose of 2 g/kg during the observation period. The extract‐treated group with normoglycemia revealed a significant lowering in BGL at the 4‐hour mark of 27.4% (p< 0.001) and 25.2% (p< 0.01) at doses of 200 mg/kg and 400 mg/kg, respectively, compared to that in negative control. In the oral glucose tolerance test (OGTT) model, only 400 mg/kg treated groups at 120 min after exposure showed a BGL reduction of 31.17% which was statistically significant (p< 0.05) in comparison to the negative control. In the single‐dose STZ‐induced model, eighth‐hour BGL measurements from CE 100, CE 200, CE 400, and GLC5 showed drops in BGL of 43.1%, 44.1%, 45%, and 47.3% from baseline fasting BGL values. In the repeated streptozotocin (STZ)‐induced model, at all doses of leaf extract and fractions, the fasting BGL was significantly (p< 0.001) reduced. Moreover, the leaf extract and solvent fractions have shown a significant (p< 0.001) reduction of serum lipids such as LDL, TC, and VLDL, and at the same time, it increases HDL at 14 days with body weight gained. In the test for antioxidant activity, the half‐maximal inhibitory concentrations (IC50) for leaf extract and the standard medication (ascorbic acid) were 8.2 μg/ml and 3.3 μg/ml, respectively. The IC50value denotes the concentration of the sample required to scavenge 50% DPPH radicals.Conclusion. The 80% hydromethanolic leaf extract and fractions ofPodocarpus gracilisexhibited blood glucose lowering, lipid‐lowering activity in normoglycemic, oral glucose tolerance test (OGTT) mode, and STZ‐induced diabetic mice with weight gains. There is scientific support for the alleged traditional use as an antidiabetic, lipid‐lowering, and antioxidant activity. The results need to be confirmed by future studies.
- 1 January 2023
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2023 (1) , 9187837
Open AccessIn VivoHypolipidemic, Hypoglycemic, Antihyperglycemic, andIn VitroAntioxidant Effects ofPodocarpus gracilisLeaf Extract and Fractions in Diabetic Mice
Background.Podocarpus gracilisis an evergreen, dioecious tree found in Ethiopia and other African nations. It can reach a height of 60 meters. Without any scientific validation, ethnobotanical studies conducted in Ethiopia revealed that thePodocarpus gracilisplant’s leaf is consumed orally to treat diabetes mellitus. Hence, this study aims to evaluate thein vivoblood glucose level lowering, lipid‐lowering, andin vitro‐free radical scavenging responses ofPodocarpus gracilis leaf extract and fractions on experimental mice induced with diabetes.Methods. Thein vitroantioxidant activity of PGC (Podocarpus gracilis) leaf extract was assessed by using a diphenyl‐2‐picrylhydrazyl (DPPH) assay. The oral glucose‐loaded, normoglycemic, and streptozotocin‐ (STZ‐) induced diabetic mouse models were employed. In the STZ‐induced mice model, the leaf extract and solvent fractions activity on serum lipid and weight were also measured. The extract and fractions were tested at 100, 200, and 400 mg/kg dosages. One‐way ANOVA was used to determine the statistical significance of BGL (blood glucose level) changes within and between groups, and Tukey’s post hoc multiple comparisons were then performed.Results. In the acute toxicity study ofPodocarpus gracilisleaf extract and fractions, there was no evidence of animal mortality at the maximum dose of 2 g/kg during the observation period. The extract‐treated group with normoglycemia revealed a significant lowering in BGL at the 4‐hour mark of 27.4% (p< 0.001) and 25.2% (p< 0.01) at doses of 200 mg/kg and 400 mg/kg, respectively, compared to that in negative control. In the oral glucose tolerance test (OGTT) model, only 400 mg/kg treated groups at 120 min after exposure showed a BGL reduction of 31.17% which was statistically significant (p< 0.05) in comparison to the negative control. In the single‐dose STZ‐induced model, eighth‐hour BGL measurements from CE 100, CE 200, CE 400, and GLC5 showed drops in BGL of 43.1%, 44.1%, 45%, and 47.3% from baseline fasting BGL values. In the repeated streptozotocin (STZ)‐induced model, at all doses of leaf extract and fractions, the fasting BGL was significantly (p< 0.001) reduced. Moreover, the leaf extract and solvent fractions have shown a significant (p< 0.001) reduction of serum lipids such as LDL, TC, and VLDL, and at the same time, it increases HDL at 14 days with body weight gained. In the test for antioxidant activity, the half‐maximal inhibitory concentrations (IC50) for leaf extract and the standard medication (ascorbic acid) were 8.2 μg/ml and 3.3 μg/ml, respectively. The IC50value denotes the concentration of the sample required to scavenge 50% DPPH radicals.Conclusion. The 80% hydromethanolic leaf extract and fractions ofPodocarpus gracilisexhibited blood glucose lowering, lipid‐lowering activity in normoglycemic, oral glucose tolerance test (OGTT) mode, and STZ‐induced diabetic mice with weight gains. There is scientific support for the alleged traditional use as an antidiabetic, lipid‐lowering, and antioxidant activity. The results need to be confirmed by future studies.
- Open Access
- 2 December 2022
- Published by Springer Nature in Research Square
Barriers to Reporting Adverse drug reaction among Health Care Providers In Ethiopia
Background: Timely adverse drug reactions (ADRs) reporting has contributed immensely towards public health safety and adverse drug reaction reporting helps the drug monitoring system to detect the unwanted effects of those drugs which are already in the market. Objective: To assess Barriers to Reporting Adverse drug reaction among Health Care Providers in Ethiopia. Method: A descriptive cross-sectional study was conducted utilizing a self-administered questionnaire from the medical staff. Questions about knowledge and attitude were scored and categorized. Bivariate and multivariate logistic regressions were used to analyze the relationship between the dependent and independent variables, with a p-value of Result: A total of 90 health care professionals were surveyed, and 54.4% of them were men. The availability of the ADRs reporting form was known by (51.1%) of the respondents, (81.1%) of them had encountered ADR during their practice. Sex (aOR: 2.63, 95% CI: 1.001, 7.33; pConclusion: From this study, it can be inferred that although health care professionals have a decent level of knowledge and a favorable attitude toward ADR reporting, there is a low level of ADR reporting and training was the only factor that determined ADRs reporting.
- 2 December 2022
- Published by Springer Nature in Research Square
Open AccessBarriers to Reporting Adverse drug reaction among Health Care Providers In Ethiopia
Background: Timely adverse drug reactions (ADRs) reporting has contributed immensely towards public health safety and adverse drug reaction reporting helps the drug monitoring system to detect the unwanted effects of those drugs which are already in the market. Objective: To assess Barriers to Reporting Adverse drug reaction among Health Care Providers in Ethiopia. Method: A descriptive cross-sectional study was conducted utilizing a self-administered questionnaire from the medical staff. Questions about knowledge and attitude were scored and categorized. Bivariate and multivariate logistic regressions were used to analyze the relationship between the dependent and independent variables, with a p-value of Result: A total of 90 health care professionals were surveyed, and 54.4% of them were men. The availability of the ADRs reporting form was known by (51.1%) of the respondents, (81.1%) of them had encountered ADR during their practice. Sex (aOR: 2.63, 95% CI: 1.001, 7.33; pConclusion: From this study, it can be inferred that although health care professionals have a decent level of knowledge and a favorable attitude toward ADR reporting, there is a low level of ADR reporting and training was the only factor that determined ADRs reporting.
- Open Access
- 28 November 2022
- Published by Springer Nature in Research Square
Retrospective Drug use Evaluation of Ceftriaxone In Resource Limited Setting In Case Of Bedele General Hospital, Ethiopia
Background: Anti-microbial resistance (AMR) due to the over use of the reserved antibiotics like ceftriaxone is one of the threatening global issues of public health and many patients suffer due to harms arising from AMR because the infections caused by viruses, bacteria, fungi, protozoa and helminthes are no longer susceptible to the commonly available antibiotics. Objective: To evaluate the utilization pattern of ceftriaxone at Medical Ward in Bedele General Hospital, Bedele, South West Oromia, Ethiopia. Methodology: Patients' medical record cards (PMRCs) from the medical ward at Bedele General Hospital who took ceftriaxone between July 1 and December 30 of 2021 were the subject of a hospital-based retrospective cross-sectional study design and the selection of the medical record cards was done using a systemic random sample technique. Utilizing current Ethiopia's Standard Treatment Guideline for General Hospital and Drug Use Evaluation Criteria, the appropriateness of the ceftriaxone usage was assessed. Results: A total of 212 patients’ medical records were reviewed and the most frequent age group was adults in the range of 18-65 (80.5%) and the use of ceftriaxone was inappropriate in 185 cases (47.1%). Ceftriaxone was mainly used for the treatment of pneumonia condition (46.2%), regarding ceftriaxone dosage in our study, the majority of patients received 2 g/day (85.4%) and the mean duration of ceftriaxone therapy in our study was 11.47 days, with a range of 2-7 days (49.7%). Maintenance fluids were the most commonly co-administered medications with a frequency of 32.9%. Conclusions: Prescribers should follow the national standard treatment guideline in order to increase rational use of ceftriaxone and stop the emergence of resistance. The hospital may choose to implement antimicrobial control systems and short-term training for health care professional in order to adhere the treatment guideline is our recommendation.
- 28 November 2022
- Published by Springer Nature in Research Square
Open AccessRetrospective Drug use Evaluation of Ceftriaxone In Resource Limited Setting In Case Of Bedele General Hospital, Ethiopia
Background: Anti-microbial resistance (AMR) due to the over use of the reserved antibiotics like ceftriaxone is one of the threatening global issues of public health and many patients suffer due to harms arising from AMR because the infections caused by viruses, bacteria, fungi, protozoa and helminthes are no longer susceptible to the commonly available antibiotics. Objective: To evaluate the utilization pattern of ceftriaxone at Medical Ward in Bedele General Hospital, Bedele, South West Oromia, Ethiopia. Methodology: Patients' medical record cards (PMRCs) from the medical ward at Bedele General Hospital who took ceftriaxone between July 1 and December 30 of 2021 were the subject of a hospital-based retrospective cross-sectional study design and the selection of the medical record cards was done using a systemic random sample technique. Utilizing current Ethiopia's Standard Treatment Guideline for General Hospital and Drug Use Evaluation Criteria, the appropriateness of the ceftriaxone usage was assessed. Results: A total of 212 patients’ medical records were reviewed and the most frequent age group was adults in the range of 18-65 (80.5%) and the use of ceftriaxone was inappropriate in 185 cases (47.1%). Ceftriaxone was mainly used for the treatment of pneumonia condition (46.2%), regarding ceftriaxone dosage in our study, the majority of patients received 2 g/day (85.4%) and the mean duration of ceftriaxone therapy in our study was 11.47 days, with a range of 2-7 days (49.7%). Maintenance fluids were the most commonly co-administered medications with a frequency of 32.9%. Conclusions: Prescribers should follow the national standard treatment guideline in order to increase rational use of ceftriaxone and stop the emergence of resistance. The hospital may choose to implement antimicrobial control systems and short-term training for health care professional in order to adhere the treatment guideline is our recommendation.
- Open Access
- 22 November 2022
- Published by Springer Nature in Research Square
Community Based Cross-sectional Study of the Knowledge, Attitude and Practice of Complementary and Alternative Medicine in Resources Limited Setting: A Case of Mettu Town, South Western of Ethiopia
Objectives The goal of the study was to evaluate the community of Mettu Town, South West Ethiopia's knowledge, attitudes, and use of complementary and alternative medicine. Methods A community-based descriptive cross-sectional study including 285 individuals in Mettu town 03 kebele was conducted. To choose the households, a standardized random sampling method was utilized and house to house interviews were used to gather the data. Results 143 people (48.9%) of the participants were female and 94.9% of the respondents used complementary and alternative medicine, and 89% were aware of it. Medical herbalism was the most often used system (50.6%), and a higher percentage of study participants thought alternative medicine was less expensive than modern medicine (30.8%) and more accessible (42.5%). Conclusion The majority of the Mettu town Community practiced Complementary and Alternative Medicine theraphy and the study participants in Mettu town have good knowledge but poor attitude regarding utilization of CAM.
- 22 November 2022
- Published by Springer Nature in Research Square
Open AccessCommunity Based Cross-sectional Study of the Knowledge, Attitude and Practice of Complementary and Alternative Medicine in Resources Limited Setting: A Case of Mettu Town, South Western of Ethiopia
Objectives The goal of the study was to evaluate the community of Mettu Town, South West Ethiopia's knowledge, attitudes, and use of complementary and alternative medicine. Methods A community-based descriptive cross-sectional study including 285 individuals in Mettu town 03 kebele was conducted. To choose the households, a standardized random sampling method was utilized and house to house interviews were used to gather the data. Results 143 people (48.9%) of the participants were female and 94.9% of the respondents used complementary and alternative medicine, and 89% were aware of it. Medical herbalism was the most often used system (50.6%), and a higher percentage of study participants thought alternative medicine was less expensive than modern medicine (30.8%) and more accessible (42.5%). Conclusion The majority of the Mettu town Community practiced Complementary and Alternative Medicine theraphy and the study participants in Mettu town have good knowledge but poor attitude regarding utilization of CAM.
- Open Access
- 28 October 2022
- Published by Taylor & Francis in Journal of Experimental Pharmacology
- Vol. ume 14, 317-330
Evaluation of in vivo Antidiabetic, Antidyslipidemic and in vitro Anti-Oxidant Activity of Extract and Solvent Fractions of Discopodium penninervum Hoschst Leaf in Mice: Normoglycemic and Streptozocin-Induced Model
Background: Diabetes mellitus has become a huge global public health and economic issue. The shortcomings of current medicines, as well as their serious side effects, prompted a focused quest for natural medicinal agents. In Ethiopia, the leaf of Discopodium penninervum Hoschst has been utilized in the traditional health system to treat diabetes. The goal of this study was to confirm the anti-diabetic, anti-dyslipidemia, and anti-oxidant activity of Discopodium penninervum Hoschst leaf in both in vitro and in vivo. Methods: In the normoglycemic, glucose-loaded, and streptozotocin-induced diabetic mouse models, the blood glucose-lowering effects of extract and solvent fractions of the leaf of Discopodium penninervum Hoschst were tested. The weight and lipid profile of streptozotocin-induced diabetic mice were assessed after treatment with leaf extract and solvent fractions for 14 days. The DPPH test was used to assess the antioxidant activity of the plant leaf extract. Results: In the normoglycemic model and glucose loaded test, the leaf extract of Discopodium penninervum Hoschst demonstrated significant blood glucose decrease (34.1%, p< 0.001) and 44.5%, p< 0.001, respectively, when compared to the normal control. When compared to a diabetic control group, extract and solvent fractions significantly (p< 0.001) reduced blood glucose levels on the 14th day in the streptozotocin-induced diabetic model. In addition, serum TC, STG, TG, LDL, and VLDL levels were reduced significantly (p< 0.001). IC50 values of leaf extract and a standard medication (ascorbic acid) in the antioxidant activity test were 4.1g/mL and 10.23g/mL, respectively. Conclusion: The hydro-alcoholic leaf extract and solvent fractions of Discopodium penninervum Hoschst leaves have demonstrated blood glucose-lowering effect, which justify ethnobotanical use, and can therefore be used as a good insight for new anti-diabetic medication source with a call for additional studies.
- 28 October 2022
- Published by Taylor & Francis in Journal of Experimental Pharmacology
- Vol. ume 14, 317-330
Open AccessEvaluation of in vivo Antidiabetic, Antidyslipidemic and in vitro Anti-Oxidant Activity of Extract and Solvent Fractions of Discopodium penninervum Hoschst Leaf in Mice: Normoglycemic and Streptozocin-Induced Model
Background: Diabetes mellitus has become a huge global public health and economic issue. The shortcomings of current medicines, as well as their serious side effects, prompted a focused quest for natural medicinal agents. In Ethiopia, the leaf of Discopodium penninervum Hoschst has been utilized in the traditional health system to treat diabetes. The goal of this study was to confirm the anti-diabetic, anti-dyslipidemia, and anti-oxidant activity of Discopodium penninervum Hoschst leaf in both in vitro and in vivo. Methods: In the normoglycemic, glucose-loaded, and streptozotocin-induced diabetic mouse models, the blood glucose-lowering effects of extract and solvent fractions of the leaf of Discopodium penninervum Hoschst were tested. The weight and lipid profile of streptozotocin-induced diabetic mice were assessed after treatment with leaf extract and solvent fractions for 14 days. The DPPH test was used to assess the antioxidant activity of the plant leaf extract. Results: In the normoglycemic model and glucose loaded test, the leaf extract of Discopodium penninervum Hoschst demonstrated significant blood glucose decrease (34.1%, p< 0.001) and 44.5%, p< 0.001, respectively, when compared to the normal control. When compared to a diabetic control group, extract and solvent fractions significantly (p< 0.001) reduced blood glucose levels on the 14th day in the streptozotocin-induced diabetic model. In addition, serum TC, STG, TG, LDL, and VLDL levels were reduced significantly (p< 0.001). IC50 values of leaf extract and a standard medication (ascorbic acid) in the antioxidant activity test were 4.1g/mL and 10.23g/mL, respectively. Conclusion: The hydro-alcoholic leaf extract and solvent fractions of Discopodium penninervum Hoschst leaves have demonstrated blood glucose-lowering effect, which justify ethnobotanical use, and can therefore be used as a good insight for new anti-diabetic medication source with a call for additional studies.